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Treatment of rat liver microsomes with 2,5-di(tert-butyl)-1,4-benzohydroquinone caused a dose-related in- 
hibition (4 z 1 ,uM) of ATP-dependent Caz+ sequestration. This was paralleled by a similar impairment 
of the microsomal Ca* +-stimulat ed ATPase activity. In contrast, the hydroquinone failed to induce Ca* + 
release from Ca* +-loaded live r mitochondria (supplied with ATP), and inhibited neither the mitochondrial 
F, F,-ATPase nor the Ca * +-stimulated ATPase activity of the hepatic plasma membrane fraction. The inhi- 
bition of microsomal Ca*+ sequestration was not associated with any apparent alteration of membrane per- 
meability or loss of other microsomal enzyme activities or modification of microsomal protein thiols. These 
findings suggest hat 2,5-di(tert-butyl)-1,4-benzohydroquinone is apotent and selective inhibitor of liver mi- 
crosomal Ca* + sequestration which may be a useful tool in studies of Ca 2+ fluxes in intact cells and tissues. 
Microsome; Ca* + sequestration; (Ca* + + MgZ +)-ATPase; 2,5-Di(tert-butyl)-1,4-benzohydroquinone; (Rat liver) 
1. INTRODUCTION 
The regulation of intracellular Ca2+ homeostasis 
has been extensively studied in recent years because 
of the important role that Ca2+ plays in mediating 
various cellular functions [ 1,2]. Particularly im- 
portant in the modulation of cytosolic free Ca2+ 
concentration is the ATP-dependent Ca2+- 
sequestration system of the hepatic endoplasmic 
reticulum [3]. There is now convincing evidence 
that the endoplasmic reticular Ca2+ pool is the 
major intracellular source of the Ca2+ release into 
the cytosol when hepatocytes are treated with 
various Ca2+-mobilizing agents [4,5]. Inositol 
1,4,5_trisphosphate appears to be a specific media- 
tor of this Ca2+ release but other endogenous com- 
pounds, such as GTP and certain arachidonic acid 
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metabolites, can also cause Ca2+ release from liver 
microsomes [5-91. 
It is well known that various drugs and 
hepatotoxins can inhibit ATP-dependent Ca2+ se- 
questration by liver microsomes. This may be the 
result of altered membrane permeability or the 
modification of protein thiol groups critical for 
microsomal Ca2+-stimulated ATPase activity 
[3,10-151. However, few xenobiotics have been 
documented to perturb selectively the endoplasmic 
reticular Ca2+ pool. For example, vanadate, a po- 
tent inhibitor of microsomal Ca2+ sequestration 
and Ca2+-stimulated ATPase activity, also inhibits 
other ATPase systems and is involved in various 
nonspecific cellular reactions [ 16- 181. 
Recently, our laboratory has been engaged in 
determining the mechanism(s) of quinone toxicity 
in hepatocytes and subcellular organelles [ 19,201. 
During these investigations we found that 
2,5-di(tert-butyl)-1 ,Cbenzohydroquinone (tBu- 
BHQ) impaired microsomal Ca2+ sequestration. 
Here, we present data demonstrating that tBuBHQ 
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inhibits ATP-dependent Ca2+ sequestration i  liver 
microsomes without affecting liver mitochondrial 
Ca2+ fluxes or the Ca2+-ATPase activity of the 
hepatic membrane fraction. 
2. MATERIALS AND METHODS 
Livers from male Sprague-Dawley rats 
(180-200 g, fed ad libitum) were used in all ex- 
periments. Hepatocytes were isolated by the col- 
lagenase perfusion method in [21]. The hepatic 
plasma membrane fraction was prepared as in [22]. 
Mitochondria were isolated by differential cen- 
trifugation according to [23]. Microsomes were 
prepared essentially as described in [24], except 
that 150 mM KCl-20 mM Hepes, pH 7.4, was used 
as the homogenizing and washing medium. Protein 
concentration was measured according to Lowry et 
al. [25]. 
Ca’+ sequestration by liver microsomes was 
measured by two independent methods. Firstly, 
45ca2+ sequestration was monitored as described 
by Moore et al. [3], with the modification that the 
microsomes were incubated in the absence of ox- 
alate in 150 mM KCl-20 mM Hepes, pH 7.1, 
subsequently referred to as incubation buffer, sup- 
plemented with 1 mM MgCl2 and 20,uM 45Ca2+ 
(0.5 &i/ml) at 37°C. Secondly, for continuous 
monitoring of Ca2+ fluxes, a Ca2+-selective elec- 
trode was used [15]; the microsomes (1 mg pro- 
tein/ml) were incubated in incubation buffer 
supplemented with ATP-Mg2+ (1 J-4.0 mM) and 
20pM Ca2+ at 37°C. Investigation of the rever- 
sibility of tBuBHQ-induced inhibition of Ca2+ se- 
questration was performed as follows. Microsomes 
(0.25 mg protein/ml) were incubated in the 
absence or presence of tBuBHQ (10 PM) at 4 and 
37°C in 20 ml incubation buffer for 10 min. The 
microsomes were then sedimented by centrifuga- 
tion, washed once, and 45Ca2+ sequestration was 
monitored as described above. Mitochondrial Ca2+ 
fluxes were measured using the Ca2+ electrode in a 
medium containing 120 mM sucrose, 60 mM KCl, 
and 3 mM Hepes, pH 7.1, supplemented with 
ATP-Mg2+ (3-4 mM) and 15 PM Ca2+, at 25°C. 
The Mg2+-dependent, Ca2+-stimulated ATPase 
activity of the plasma membrane fraction was 
measured as in [26]. Mitochondrial FIFO-ATPase 
activity was determined as in [27]. In brief, 
mitochondria (1 mg protein/ml) were prein- 
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cubated in the absence or presence of tBuBHQ for 
2.5 min at 25°C. The reaction was then initiated by 
the addition of 5 mM ATP, and maximal activity 
obtained by the addition of 1 PM CCCP (carbonyl 
cyanide m-chlorophenylhydrazone). Microsomal 
ATPase activity was determined essentially ac- 
cording to Dawson and Fulton [ 171, except that in- 
cubation buffer was used and [Pi] was determined 
as in [28]. 
Reduced protein sulfhydryl groups were 
measured using Ellman’s reagent (dithiobisdinitro- 
benzoic acid) as described [151. Lipid peroxidation 
was assayed as in [29]. 
The effects of tBuBHQ on microsomal enzyme 
activities and cytochrome P-450 content were 
studied by incubating microsomes (1 mg/ml) in in- 
cubation buffer in the absence or presence of 
tBuBHQ (20 or 2OOpM) for 15 min at 30°C. 
Glucose-6-phosphatase, NADPH-cytochrome c 
reductase, and cytochrome P-450 content were 
then assayed [30-321. 
All chemicals were of the highest purity com- 
mercially available. tBuBHQ (97% pure) was ob- 
tained from Aldrich. 2,5-Di(tert-butyl)-1,4-benzo- 
quinone was synthesized by oxidation of tBuBHQ 
with AgzO (5 equiv.) in dry diethyl ether until com- 
pletion. The quinone was then crystallized from 
petroleum ether (b.p. 30-40°C). 
3. RESULTS AND DISCUSSION 
The experiment shown in fig. 1 demonstrates the 
inhibition of ATP-dependent Ca2+ sequestration 
in liver microsomes by tBuBHQ. Half-maximal 
and maximal effects occurred at about 1 x 10e6 
and 1 x 10e5 M tBuBHQ, respectively. Preincuba- 
tion of microsomes with tBuBHQ (10 PM) at either 
4 or 37°C followed by washing as described in sec- 
tion 2 did not reverse tBuBHQ-induced inhibition 
(not shown). The hydroquinone also inhibited the 
microsomal Ca2+ -stimulated ATPase activity in a 
dose-dependent manner (fig.2); half-maximal and 
maximal inhibition was obtained with about 5 x 
lo-’ and 2 x 10e6 M tBuBHQ, respectively. In 
contrast, the Ca2+-independent Mg2+-ATPase ac- 
tivity was not affected by tBuBHQ. 
Possible mechanisms of tBuBHQ inhibition of 
microsomal Ca2+ sequestration include the 
modification of essential protein thiols (cf. [3,151) 
Volume 224. number 2 FEBS LETTERS November 1987 
6 I 
s 
-8 -7 -6 -5 -4 
LOG MOLAR CONCENTRATION 
Fig.1. tBuBHQ-induced inhibition of Ca2+ 
sequestration by liver microsomes. Microsomes were 
incubated for 15 min at 37°C with tBuBHQ at the 
indicated concentrations before rapid filtration (see 
section 2 for details). The incubation medium for 
measuring Ca’+ sequestration contained in a final 
volume of 1 ml: 1 mM MgC12, 20 PM Ca2+ (0.5 &i/ml 
45Ca2+), and 150 mM KCl-20 mM Hepes, pH 7.1. The 
reaction was initiated by the addition of 5 mM ATP plus 
microsomes (0.25 mg protein/ml), final concentrations. 
Under these conditions 6.2 f 0.5 nmol Ca’+/mg protein 
(x + SD, n = 5) were sequestered within 5 min and could 
be retained for up to 30 min. Each point either 
represents the mean of two or mean k SD of three 
determinations. 
and alteration of microsomal membrane 
permeability. However, incubation of liver 
microsomes in the presence of tBuBHQ, or its 
quinone (up to lOOpM), for 1 h did not result in 
a measurable loss of protein thiols. Furthermore, 
the presence of either dithiothreitol (5 mM) or 
reduced glutathione (2 mM) did not prevent 
tBuBHQ-induced inhibition of Ca2+ sequestration 
(not shown). It seems unlikely that nonspecific 
membrane effects would be responsible for the 
tBuBHQ inhibition since the structurally related 
tert-butyl analogs, 3,5-di(tert-butyl)-4-hydroxytol- 
uene (BHT) and 3(2)-tert-butyl-4-hydroxyanisole 
(BHA), were not inhibitory even at concentrations 
up to 1 mM. In addition, microsomal ipid peroxi- 
dation was not observed (not shown) and the ac- 
tivities of glucose-6-phosphatase and NADPH- 
cytochrome c reductase were not altered, whereas 
the cytochrome P-450 content was only slightly 
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Fig.2. Effects of tBuBHQ on liver microsomal ATPase 
activity. The ATPase assay is described in section 2. 
Microsomes were preincubated with the indicated 
concentrations of tBuBHQ for 2 min before addition of 
ATP. (0) 1 mM EGTA and 28 pM Ca2+ (free [Ca’+] = 
16 nM); (0) 0.1 mM EGTA and 77pM Ca2+ (free 
[Ca”] = 1.76pM). (Inset) Effect of tBuBHQ on 
(Ca’+ + Mg’+)-ATPase activity. 
decreased by treatment of the microsomes with 
200,~M tBuBHQ (table 1). 
Since tBuBHQ potently inhibits both 
microsomal Ca2+ sequestration and Ca2+-stimu- 
lated ATPase activity, further experiments were 
conducted to investigate possible effects of 
tBuBHQ on other hepatic Ca2+-transport systems. 
As shown in fig.3, isolated rat liver microsomes 
and mitochondria, which had accumulated Ca2+ in 
the presence of ATP, responded differently to the 
addition of the benzohydroquinone. Microsomes 
exhibited dose-dependent Ca2+ release between 2.5 
and 10 PM tBuBHQ (fig.3A). At 20 ,uM the rate of 
Ca2+ release was maximal. Interestingly, at 10 and 
20 PM tBuBHQ, Ca2+ release was biphasic. These 
results were independently confirmed by the 
measurement of 45Ca2+ release using the same con- 
ditions as in fig.1 (not shown). In contrast, 
Ca2+-loaded mitochondria, energized by ATP- 
Mg2+ (3-4 mM), did not release Ca2+ even at con- 
centrations up to 400,~M tBuBHQ (fig.3B). Fur- 
thermore, neither the mitochondrial FIFO-ATPase 
333 
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Table 1 
Effect of tBuBHQ on microsomal enzyme activities and cytochrome P-450 content 
Additions Glucose-6-phosphatasea NADPH-cytochrome c P-450c 
reductaseb 
None 170 * 12 69 f 13 0.53 f 0.04 
tBuBHQ (20 PM) 184 f 11 72 + 10 N.D. 
(200 PM) 183 + 10 79+ 11 0.41 * 0.04 
Microsomes (1 mg/ml) were preincubated with tBuBHQ before determination of 
enzyme activities and cytochrome P-450 content as described in section 2. a nmol 
Pi ’ min-’ . mg-’ protein; b nmol cytochrome c reduced. min-’ . mg-’ protein; 
’ nmol.mg-’ protein. N.D., not determined. Values represent means + SD of 3-4 
determinations 
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Fig.3. tBuBHQ-induced Ca’+ release from Ca’+-loaded 
microsomes (A) and mitochondria (B). Ca’+ loading was 
initiated by the addition of either microsomes (1 mg 
protein/ml) or mitochondria (1 mg protein/ml). When a 
steady Ca 2+ level was reached, the benzohydroquinone 
was added at the concentrations indicated (incM). Other 
additions: (I) A23187 (2 pM); (A), antimycin A (2 PM); 
and (0), oligomycin (0.5 pM). Downward and upward 
deflections correspond to uptake and release of Ca2+, 
respectively. 
(not shown) nor the Ca*+-stimulated ATPase ac- 
tivity of the hepatic plasma membrane fraction 
was inhibited by tBuBHQ (fig.4). 
Several lines of evidence suggest hat the effects 
of tBuBHQ are selective for the microsomal 
Ca*+-sequestration system. Firstly, alterations of 
the microsomal membrane integrity seem unlikely 
to occur, since no lipid peroxidation was observed 
and relatively high concentrations of structurally 
I I , I 
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Fig.4. Lack of effect of tBuBHQ on plasma membrane 
Ca’+-ATPase activity. A suspension of polyacrylamide 
beads with attached plasma membrane fragments 
(0.2-0.25 mg protein/ml), isolated from untreated 
hepatocytes, was incubated in the absence (0) or 
presence (0) of tBuBHQ (20 PM) for 5 min at 37°C 
before adding ATP (1 mM). After 60 min the reaction 
was stopped and [Pi] measured as described in section 2. 
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similar analogs (BHT and BHA) did not impair 
Ca2+ sequestration. Secondly, the lack of both 
alteration of microsomal protein sulfhydryls and 
NADPH-cytochrome c reductase activity, an en- 
zyme critically dependent on thiols for activity, 
demonstrates that neither arylation nor oxidation 
of these groups occurred. Previously, we have 
shown that 2,5dimethylbenzoquinone rapidly 
arylates GSH [20]. However, incubation of either 
tBuBHQ or its quinone with GSH did not result in 
loss of GSH (not shown), suggesting that the tert- 
butyl groups sterically hinder Michael-type addi- 
tion reactions on the ring. The possibility remains, 
however, that tBuBHQ may alkylate other critical 
protein groups. Thirdly, competition of tBuBHQ 
with Ca2+ or Mg2+ is ruled out because the effects 
of tBuBHQ were not reversed by washing follow- 
ing preincubation of microsomes with tBuBHQ at 
either 4 or 37°C. Finally, inhibition of the 
(Ca2+ + Mg’+)-stimulated ATPase activity and im- 
pairment of Ca2+ sequestration occurred within a 
similar concentration range suggesting that these 
two events may be associated. That maximal in- 
hibition of the (Ca2+ +Mg2+)-ATPase activity by 
tBuBHQ occurred at 2 x 10Y6 M compared with 
the 1 x lo-’ M required to impair Ca2+ sequestra- 
tion may depend on the different assay conditions 
used. Measurement of Ca2+ sequestration in the 
absence of the Ca2+ ionophore A23187 [cf. 
(Ca2+ + MgZC)-ATPase activity], results in a 
relatively higher intramicrosomal Ca2+ concentra- 
tion which may partially reverse tBuBHQ inhibi- 
tion. Similar effects have been observed with 
vanadate [ 171. 
In conclusion, our findings demonstrate that 
tBuBHQ is a potent inhibitor of liver microsomal 
Ca’+-stimulated ATPase activity and Ca2+ se- 
questration, without apparent modification of 
protein thiols or the integrity of the microsomal 
membrane. Mitochondrial Ca2+ sequestration and 
FIFO-ATPase activity, as well as the 
Ca’+-stimulated ATPase activity of the plasma 
membrane fraction, are not affected by the hydro- 
quinone. It appears therefore that tBuBHQ is a 
selective inhibitor of microsomal Ca2+ sequestra- 
tion, and that this is associated with the loss of 
Ca’+-stimulated ATPase activity. It is suggested 
that the hydroquinone may be a useful tool in the 
further elucidation of the contribution of the en- 
doplasmic reticulum to the maintenance of Ca2+ 
homeostasis in hepatocytes and, possibly, other 
cells. 
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